Epsilon M&A Deal Report - NewLab BioQuality
Transaction Multiples for the Valuation of Private Companies
Charles River Laboratories International / NewLab BioQuality
No EMAT :
19262
Announced Date :
04/08/2008
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Charles River Laboratories International
Target :
NewLab BioQuality
Country :
Germany
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
Business Description :
NewLab BioQuality AG provides quality control analysis for biopharmaceutical drugs . > The company provides various services, including genetic stability testing, determination of copy number, DNA...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
| Date | Acquirer | Target | Country | Multiples | See details |
| 09/07/2008 | Diasorin | Biotrin Group | Ireland | *** | 19236 |
| 14/08/2008 | Nanogen | Elitech Group | France | ** | 19216 |
Source: Epsilon Research / EMAT
